These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24916890)

  • 1. A prognostic classifier consisting of 17 circulating cytokines is a novel predictor of overall survival for metastatic colorectal cancer patients.
    Chen ZY; He WZ; Peng LX; Jia WH; Guo RP; Xia LP; Qian CN
    Int J Cancer; 2015 Feb; 136(3):584-92. PubMed ID: 24916890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohorts.
    Chen ZY; Wei W; Guo ZX; Peng LX; Shi M; Li SH; Xiao CZ; Zhong C; Qian CN; Guo RP
    Br J Cancer; 2014 Feb; 110(3):733-40. PubMed ID: 24495874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum concentration of monocyte chemotactic protein 4 (MCP-4) as a novel non-invasive prognostic and predictive biomarker for detection of metastasis in colorectal cancer.
    Okugawa Y; Toiyama Y; Mohri Y; Tanaka K; Kawamura M; Hiro J; Araki T; Inoue Y; Miki C; Kusunoki M
    J Surg Oncol; 2016 Sep; 114(4):483-9. PubMed ID: 27349356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.
    Shah MS; Fogelman DR; Raghav KP; Heymach JV; Tran HT; Jiang ZQ; Kopetz S; Daniel CR
    Cancer; 2015 Sep; 121(17):2968-75. PubMed ID: 25975416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
    Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
    Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer.
    Chen ZY; Raghav K; Lieu CH; Jiang ZQ; Eng C; Vauthey JN; Chang GJ; Qiao W; Morris J; Hong D; Hoff P; Tran H; Menter DG; Heymach J; Overman M; Kopetz S
    Br J Cancer; 2015 Mar; 112(6):1088-97. PubMed ID: 25688736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
    Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
    J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance.
    Krzystek-Korpacka M; Diakowska D; Kapturkiewicz B; Bębenek M; Gamian A
    Cancer Lett; 2013 Aug; 337(1):107-14. PubMed ID: 23726839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer.
    Spindler KL; Appelt AL; Pallisgaard N; Andersen RF; Brandslund I; Jakobsen A
    Int J Cancer; 2014 Dec; 135(12):2984-91. PubMed ID: 24798213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating midkine in malignant and non-malignant colorectal diseases.
    Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
    Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis.
    Rutkowski P; Kaminska J; Kowalska M; Ruka W; Steffen J
    Int J Cancer; 2002 Aug; 100(4):463-71. PubMed ID: 12115531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome.
    Stayoussef M; Weili X; Habel A; Barbirou M; Bedoui S; Attia A; Omrani Y; Zouari K; Maghrebi H; Almawi WY; Bouhaouala-Zahar B; Larbi A; Yacoubi-Loueslati B
    Cancer Immunol Immunother; 2024 Jul; 73(9):169. PubMed ID: 38954024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier).
    Gündert M; Edelmann D; Benner A; Jansen L; Jia M; Walter V; Knebel P; Herpel E; Chang-Claude J; Hoffmeister M; Brenner H; Burwinkel B
    Gut; 2019 Jan; 68(1):101-110. PubMed ID: 29101262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the prognostic factors of colorectal cancer and on suggested model for prediction].
    Liu W; Nie SF; Chen JG; Huang T; He JJ; Liu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jul; 28(7):700-3. PubMed ID: 18069564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).
    Hoff PM; Hochhaus A; Pestalozzi BC; Tebbutt NC; Li J; Kim TW; Koynov KD; Kurteva G; Pintér T; Cheng Y; van Eyll B; Pike L; Fielding A; Robertson JD; Saunders MP
    J Clin Oncol; 2012 Oct; 30(29):3596-603. PubMed ID: 22965965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
    He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
    Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKA RIα/A-kinase anchoring proteins 10 signaling pathway and the prognosis of colorectal cancer.
    Wang M; Li Y; Wang R; Wang Z; Chen K; Zhou B; Zhou Z; Sun X
    J Gastroenterol Hepatol; 2015 Mar; 30(3):496-503. PubMed ID: 25213315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLIC4, ERp29, and Smac/DIABLO derived from metastatic cancer stem-like cells stratify prognostic risks of colorectal cancer.
    Deng YJ; Tang N; Liu C; Zhang JY; An SL; Peng YL; Ma LL; Li GQ; Jiang Q; Hu CT; Wang YN; Liang YZ; Bian XW; Fang WG; Ding YQ
    Clin Cancer Res; 2014 Jul; 20(14):3809-17. PubMed ID: 24916695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.